To prohibit stock sales by senior bank executives in certain circumstances.

HR7887, the "Incentivizing Safe and Sound Banking Act," directly amends Section 8 of the Federal Deposit Insurance Act (12 U.S.C. 1818) to prohibit senior executives at covered banking institutions from selling company stock received as compensation under specific conditions. These conditions include a composite or component rating of 3, 4, or 5 under the Uniform Financial Institutions Rating System (CAMELS rating) or the issuance of a "matter requiring immediate attention" (MRA) by a federal banking agency, if the issue is not remediated by the established deadline. This prohibition remains in effect until the matter is resolved to the agency's satisfaction. Covered institutions are defined as bank holding companies or banks/savings associations with more than $50 billion in consolidated assets. This bill fundamentally alters the risk-reward profile for senior executives at major financial institutions, making their compensation directly contingent on sustained positive regulatory standing. There is no direct funding or appropriation associated with this bill. The impact is regulatory, shifting the financial incentives for executives. The money trail is indirect: executives at institutions facing regulatory issues will find their personal wealth tied up in illiquid company stock, potentially leading to increased pressure to resolve regulatory deficiencies quickly. This also creates a disincentive for executives to join or remain at institutions with a history of regulatory problems. The bill does not create new revenue streams for any companies; instead, it imposes a new constraint on executive compensation and liquidity. Historically, similar legislation directly targeting executive compensation in response to financial crises has seen mixed market reactions. Following the 2008 financial crisis, the Dodd-Frank Act included provisions on executive compensation, such as clawback rules. While not directly comparable to a stock sale prohibition, these measures aimed to align executive incentives with long-term institutional health. In the immediate aftermath of Dodd-Frank's passage in July 2010, major bank stocks like $JPM, $BAC, and $WFC experienced short-term volatility but no sustained, dramatic downturn solely attributable to executive compensation rules. However, the current bill's direct restriction on stock sales is a more immediate and personal financial constraint on executives, which could lead to different behavioral responses. Specific companies that stand to lose are the large financial institutions with over $50 billion in assets, as their senior executives face increased personal financial risk. This includes major banks such as JPMorgan Chase ($JPM), Bank of America ($BAC), Wells Fargo ($WFC), Citigroup ($C), Goldman Sachs ($GS), and Morgan Stanley ($MS). Executives at these institutions will have their compensation directly impacted if their banks receive poor regulatory ratings. There are no clear winners from this legislation, as it imposes a new regulatory burden and financial constraint on executives across the large banking sector. The bill's sponsor, Rep. Waters, is the Ranking Member of the House Financial Services Committee, indicating significant legislative momentum for this type of financial regulation. The next step is for HR7887 to be considered by the House Financial Services Committee. If it passes committee, it would then proceed to a full House vote. The timeline for passage is uncertain, but the sponsorship by a senior committee member suggests it will receive attention. If enacted, the provisions would take effect immediately, impacting any senior executive officer at a covered banking institution once the specified regulatory conditions are met. This creates an ongoing risk for executives at all large banks, forcing them to prioritize regulatory compliance to maintain liquidity of their compensation.